Proair Inhaler is a brand name for an albuterol sulfate metered-dose inhaler used to deliver medication directly to the lungs. Its therapeutic purpose is to relax bronchial smooth muscle and improve airflow in patients with reversible obstructive airway disease such as asthma. The drug functions as a selective beta-2 adrenergic receptor agonist that stimulates intracellular signaling pathways leading to muscle relaxation. Activation of these receptors increases cyclic amp production, which inhibits the release of inflammatory mediators and reduces bronchoconstriction. The inhaled delivery ensures rapid onset of action as the medication reaches the airway epithelium and vasculature directly. Systemic absorption is minimal, allowing targeted bronchodilation while limiting exposure of other organ systems. Overall the medication provides quick relief of wheezing, shortness of breath, and chest tightness by maintaining open airways during acute episodes.

The Proair Inhaler is a short-acting bronchodilator used to treat acute asthma symptoms. It belongs to the class of beta-2 agonists that relax airway smooth muscle. The medication works by stimulating beta-2 receptors on bronchial smooth muscle cells leading to increased cyclic adenosine monophosphate and subsequent muscle relaxation. This action opens the airways and improves airflow to the lungs. The effect is rapid onset and lasts for several hours providing relief during acute episodes. Its therapeutic role is to deliver a fast-acting bronchodilatory response that restores breathing comfort.

One common side effect is mild throat irritation that usually resolves on its own. Some users may experience temporary heart palpitations or a rapid heartbeat. Nervousness or feeling jittery can occur shortly after inhalation. Rarely a metallic taste may be noticed in the mouth. Headaches are occasionally reported after use. Inhalation may lead to a slight increase in blood pressure in sensitive individuals. Most side effects are mild and do not require medical attention.

Proair Inhaler may cause mild throat irritation or a tickling sensation in the oral cavity after use. Some users experience a rapid or irregular heartbeat known as tachycardia. Headache and dizziness are reported side effects in a small number of patients. In rare cases the medication can lead to tremor or feeling of nervousness. Oral dryness and mild tongue soreness have been observed during treatment. Nausea or an upset stomach may occur shortly after inhalation. Visual disturbances such as blurred vision are uncommon but have been documented. Sensitivity to the propellant may cause skin rash or localized irritation at the application site.